Clinical Trial Update: Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating dynamic contrast-enhanced MRI in patients with advanced breast or pancreatic cancer with liver or lung metastases has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Pancreatic Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas | Phase 1 | Status: WITHDRAWN